CFCThe Compounder Score
MASS logo

MASS — 908 Devices Inc.

Medical DevicesHealthcare

$9.74

$-0.05 (-0.51%)

908 Devices Inc. provides purpose-built handheld mass spectrometry and fourier transform infrared (FTIR) devices for use in vital health and safety applications. The company's products include MX908, a handheld, battery-powered, and Mass Spec device that is designed for rapid analysis of solid, liquid, vapor, and aerosol materials of unknown identity; XplorIR, a handheld device that uses FTIR spectroscopy to identify, quantify, and track gases and vapors; ThreatID, a portable FTIR device that rapidly detects and identifies approximately 28,000 unknown gas, vapor, powder, and liquid chemical hazards; ProtectIR, a handheld FTIR device that can identify approximately 23,000 solid and liquid chemical hazards; and VipIR, a handheld 3-in-1 analyzer that integrates FTIR, Raman spectroscopy, and smart spectral processing (SSP), a proprietary algorithm, to provide a single result from just one sample.

Market Cap

$405.01M

Forward P/E

-22.5x

52-Week Range

N/A

MASS Price History

No cached price history available for this ticker yet.

Revenue vs. Net Income

$56.2M

Revenue · FY2025

Annual. Net margin is shown under each year.

RevenueNet income (green profit, red loss)

Free Cash Flow

-$24.6M

FCF · FY2025

Annual. FCF margin is shown under each year.

Return on Capital Employed (ROCE)

-16.5%

ROCE · FY2025

Annual. Green above 0%, red below. Dashed line marks the 15% compounder threshold.

Total Assets vs. Total Liabilities

4.1x

Assets ÷ liabilities · FY2025

Annual. What the company owns against what it owes. Assets ÷ liabilities is shown under each year.

Total assetsTotal liabilities

CapEx as % of Revenue

1.7%

CapEx · FY2025

Annual. Green at or under the 5% maximum target, red above it.

Shares Outstanding

+5.3%

Dilution · FY2025

Annual diluted shares. Under each year: the change on the previous year (green = buyback, amber = dilution).